Environmental factors as disease accelerators during chronic hepatitis C

Area of Science:

• Hepatology
• Gastroenterology
• Infectious Diseases

Background:

• Chronic hepatitis C progression varies due to host, viral, and environmental factors.
• Environmental factors, especially substance use, are increasingly recognized as critical in hepatitis C virus (HCV) infection outcomes.
• High alcohol consumption synergistically accelerates liver fibrogenesis with HCV infection.

Purpose of the Study:

• To investigate the impact of environmental factors, including alcohol, tobacco, and cannabis use, on the progression of chronic hepatitis C.
• To highlight the role of these co-morbidities in liver fibrosis and steatosis severity.
• To inform patients about the risks associated with substance use and encourage abstinence.

Main Methods:

• Review of epidemiological and experimental studies examining the effects of alcohol, cigarette smoking, and cannabis use on HCV-related liver disease.
• Analysis of data linking substance use patterns to fibrosis progression and steatosis severity in HCV-infected individuals.
• Examination of pathogenic mechanisms, including cannabinoid receptor involvement in liver fibrogenesis.

Main Results:

• High alcohol intake combined with HCV infection accelerates liver fibrogenesis.
• Even light alcohol consumption may worsen fibrosis progression.
• Cigarette smoking may increase liver disease activity and fibrosis progression.
• Regular cannabis smoking is an independent predictor of fibrosis and steatosis severity in HCV patients.
• Cannabinoid CB1 receptors are implicated in enhancing liver fibrogenesis and steatogenesis.

Conclusions:

• Alcohol, tobacco, and cannabis use have deleterious effects on chronic hepatitis C progression.
• These substances independently predict and exacerbate liver fibrosis and steatosis.
• Patients with HCV should be counseled on the risks of substance use and supported in achieving abstinence.